Skip to search formSkip to main contentSkip to account menu

DMP 728

Known as: DMP-728, DMP728 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (3)

Cyclic PeptidesMesylatesPlatelet Aggregation Inhibitors

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2000
Highly Cited
2000
Comparative in vitro efficacy of different platelet glycoprotein IIb/IIIa antagonists on platelet-mediated clot strength induced by tissue factor with use of thromboelastography: differentiation…
In the present study, the in vitro efficacy of different platelet glycoprotein IIb/IIIa (GPIIb/IIIa) antagonists on platelet… 
1999
1999
Correlation between the in vivoEff icacy of GPIIb/IIIa Receptor Antagonists (m7E3, MK-383 and DMP-728) and ex vivo Platelet Inhibition
In vivo antithrombotic efficacy of GPIIb/IIIa receptor antagonists (m7E3, MK-383 and DMP-728) was studied with respect to their… 
1998
1998
Inhibition of platelet-mediated clot retraction by integrin antagonists.
1998
1998
Antiplatelet Efficacy of XV 459 , A Novel Nonpeptide Platelet GPIIb / IIIa Antagonist : Comparative Platelet Binding Profiles with c 7 E 3
Recent advances in the development of i.v. platelet glycoprotein aIIb/b3 integrin (GPIIb/IIIa) antagonists led to the development… 
1995
1995
A monoclonal antibody that recognizes the GPIIb/IIIa antagonist DMP 728. Reversal of the effects of DMP 728 on platelet aggregation and bleeding time in the dog.
Since hemorrhagic events represent a major safety concern associated with the use of new antithrombotic therapies such as… 
1994
1994
Thrombolytic and antithrombotic efficacy of the platelet GPIIb-IIIa antagonist DMP728.
OBJECTIVE This study was undertaken to determine the antithrombotic and thrombolytic efficacy of DMP728 alone and in conjunction… 
1994
1994
Prevention of thrombosis and rethrombosis and enhancement of the thrombolytic actions of recombinant tissue‐type plasminogen activator in the canine heart by DMP728, a glycoprotein IIb/IIIa…
1 We studied DMP728, a non‐peptide glycoprotein (GP) IIb/IIIa receptor antagonist, for prevention of coronary artery thrombosis… 
1994
1994
Intravenous antiplatelet efficacy and safety of the platelet GPIIb/IIIa antagonist, DMP 728 in anesthetized dogs.
1993
1993
Antiplatelet efficacy and specificity of DMP728, a novel platelet GPIIb/IIIa receptor antagonist.
The present study was undertaken to define the platelet GPIIb/IIIa affinity and specificity of DMP728, the cyclic [(D-2… 
1992
1992
Synthesis and alkali metal binding properties of "upper rim" functionalized calix[4]arenes
Linnane P, et al., (1994) Calixarenes: adaptable hosts par excellence. Chemistry.and Industry. 20:811, 1994. Nigam et al… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)